started · updated
BarePharm initiates KOSDAQ IPO process
BarePharm, a pharmacy platform specialist, has officially commenced its initial public offering (IPO) process to list on the KOSDAQ market. The company held an investor briefing in Seoul, setting a target offering price range between 16,400 and 20,200 KRW per share. The total expected offering amount is estimated to be between 29.2 billion and 36 billion KRW.
BarePharm has established a significant network, connecting approximately 90% of pharmacies nationwide in South Korea, with a cumulative transaction value exceeding 7.2 trillion KRW. The company reported a successful turnaround to profitability in the first half of the year, achieving 69 billion KRW in revenue and 2.2 billion KRW in operating profit.
The proceeds from the IPO are intended to fund three strategic areas: advancing AI-based supply and demand forecasting and drug identification technologies, expanding the 'Levicle' derma-cosmetic brand into US and Japanese markets, and establishing dedicated production facilities to complete its healthcare value chain.